Clinical TrialID 4838

The Effects of Fat and Theobromine on apoA-I

NCT02085109

Cardiovascular Diseases

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
4838
Evidence Id
4838
Core Evidence Id
4838
Source Clinical Trial Id
4813
Herb2 Clinical Trial Id
HBCT004813
Nct Id
NCT02085109
Title
The Effects of Fat and Theobromine on apoA-I
Status
Completed
Phase
Study Result
No
Study Condition
Cardiovascular Diseases
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Intervention
DIETARY_SUPPLEMENT: Fat milkshake|DIETARY_SUPPLEMENT: Theobromine
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Triple
Intervention Purpose
Prevention
Gender
Male
Age
Adult
Enrollment
10
Outcome Measure
Microarray, On each 3 test days 5 hours after the postprandial meal a biopsy will be taken. From these intestinal cells gene expression profiles will be measured by microarray., up to 3 days
Sponsor Collaborator
Maastricht University Medical Center
Funded By
OTHER
Location
Maastricht University Hospital, Maastricht, 6202, Netherlands
Other Id
METC 13-3-049
Start Date
2014-02
Primary Completion Date
2014-07
Completion Date
2014-07
First Posted
2014-03-12
Results First Posted
Last Update Posted
2014-08-05
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02085109
Title Cn
Title En
The Effects of Fat and Theobromine on apoA-I
Bilingual Status
semi_complete